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FemalesTwo pesticide mixtures were investigated for potential endocrine activity. Mix 3 consisted of bitertanol,
propiconazole, and cypermethrin, and Mix 5 included malathion and terbuthylazine in addition to the three
pesticides in Mix 3.
All ﬁve single pesticides and the twomixtures were investigated for their ability to affect steroidogenesis in vitro
in H295R cells. The pesticides alone and both mixtures affected steroidogenesis with both mixtures causing
increase in progesterone and decrease in testosterone. For Mix 5 an increase in estradiol was seen as well, indi-
cating increased aromatase activity.
The twomixtures were also investigated in pregnant rats dosed from gestational day 7 to 21, followed by exam-
ination of dams and fetuses. Decreased estradiol and reduced placental testosterone were seen in dams exposed
to Mix 5. Also a signiﬁcant increase in aromatase mRNA-levels in female adrenal glands was found for Mix5.
However, either of the two mixtures showed any effects on fetal hormone levels in plasma or testis, or on
anogenital distance.
Overall, potential aromatase induction was found for Mix 5 both in vitro and in vivo, but not for Mix 3, an effect
likely owed to terbuthylazine in Mix 5. However, the hormonal responses in vitro were only partly reﬂected
in vivo, probably due to some toxicokinetic issues, as the pesticide levels in the amniotic ﬂuid also were found
to be negatively affected by the number of compounds present in the mixtures. Nonetheless, the H295R assay
gives hints on conceivable interference with steroidogenesis, thus generating hypotheses on in vivo effects.
© 2013 The Authors. Published by Elsevier Inc. Open access under CC BY-NC-ND license.Introduction
The high prevalence of disorders related to the endocrine system, e.g.
fertility problems and congenitalmalformations of reproductive organs,
has been of growing concern for several years. Genetic, environmental
and lifestyle factors are likely to be involved in these adverse effects,
and one of these factors is developmental exposure to endocrine active
compounds (EACs) (IPCS, 2002).
Humans are exposed to amixture of several EACs (Blount et al., 2000;
Swan et al., 2005), and during the last decade, scientiﬁc and regulatory
focus has gradually shifted towards taking mixture effects into account.
In studies where experimental animals have been exposed simulta-
neously to several EACs, e.g. pesticides, substantialmixture effects on re-
productive development have been seen, even though each of thec. Open access under CC BY-NC-ND liceindividual compounds was present at low doses, where no effects
were seen (Hass et al., 2007, 2012; Jacobsen et al., 2012; Metzdorff
et al., 2007; Silva et al., 2002). In addition, there are indications that cu-
mulative exposure to EACs such as pesticides may play a role causing
adverse effects on human development. In epidemiological studies pos-
sible association between risk of cryptorchidism andmaternal pesticide
exposure has been reported (Andersen et al., 2008; Carbone et al., 2007;
Kristensen et al., 1997; Weidner et al., 1998). Because the adverse ef-
fects of some pesticide mixtures occur at exposure levels at which the
single pesticides do not cause adverse effects, it raises concerns about
their potential combined impact on human health. Thus, there is a
need for continued research on the effect of combined exposure in
order to gain more knowledge on mixture effects.
The present study forms part of a larger project, in which an initial
screening of 13 currently used pesticides was performed, applying a
battery of in vitro assays, including assays for effects on the estrogen
receptor (ER), the androgen receptor (AR), the aryl hydrocarbon recep-
tor (AhR), the thyroid hormone receptor (TR), and steroidogenesis
(Kjeldsen et al., 2013). The aim of the screening was to reveal potential
mechanisms of action as well as to determine the potency of thense.
Table 1
Pesticides included in the study.
Pesticide Chemical structure CAS number
Bitertanol 55179-31-2
Propiconazole 60207-90-1
Cypermethrin 52315-07-8
Malathion 121-75-5
Terbuthylazine 5915-41-3
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cides that were registered and approved for use in Denmark (except for
malathion prohibited in 2008) as well as their endocrine disrupting po-
tential, as described both in the open literature and in draft assessment
reports (DARs). The overall aim of the project was to evaluate the pre-
dictability of the in vitro tests for potential endocrine disrupting effects
in vivo. Based on the initial in vitro tests ﬁve pesticides were selected
for further study. The ﬁve pesticides chosen for the current study
represent different classes of pesticides, and included the fungicides
bitertanol and propiconazole, the insecticides cypermethrin and
malathion, and the herbicide terbuthylazine. The selection of pesticides
was based on their potency and efﬁcacy in the initial in vitro tests, with a
special focus on data from the H295R steroidogenesis assay. The ﬁve
pesticides were mixed in two different mixtures. A mixture named
“Mix 3” consisting of: bitertanol, propiconazole, and cypermethrin
mixed in the ratio 1:1:1 and a mixture called “Mix 5” consisting of all
ﬁve pesticides mixed in a 1:1:1:1:1 ratio.
In the present study the aim was to investigate the potential endo-
crine disrupting effects of the selected pesticide mixtures in vitro using
the H295R steroidogenesis assay, and in vivo in an in utero exposure
rat study. In the in vitro experiment all ﬁve single pesticides were tested
in addition to the two mixtures. For the in vitro study the intention was
not to perform anymixturemodeling ormixture predictions, but rather
to compare the effect of the single pesticides to the effects of the mix-
tures to see if we by intuition were able to predict the qualitative re-
sponse of the mixtures.
In the in vivo study pregnant rats were dosed with the two pesticide
mixtures from gestation day (GD) 7 to 21. At GD 21 fetuses were re-
moved by cesarean section, and various endpoints were measured to
examine potential endocrine disrupting effects of the mixtures.
Material and methods
Chemicals
Cypermethrin, PESTANAL®, analytical standard (CASno. 52315-07-8),
malathion, PESTANAL®, analytical standard (CAS no. 121-75-5),
bitertanol PESTANAL®, analytical standard (CAS no. 55179-31-2),
propiconazole PESTANAL®, analytical standard (CAS no. 60207-90-1),
and terbuthylazine PESTANAL®, analytical standard (CAS no. 5915-
41-3) were all purchased from Sigma-Aldrich (St. Louis, USA). The test
compounds were dissolved in corn oil (no. C8267-2.5L) for the in vivo
study or in dimethyl sulfoxide (DMSO, CAS 67-68-5) for the in vitro
studies, respectively, both from Sigma-Aldrich (St. Louis, USA). Table 1
lists the names, chemical structures and CAS numbers of the pesticides.
H295R assay
Cell culture and chemicals. The effects of the single pesticides and the
two pesticidemixtures on the production of progesterone, testosterone,
and estradiol were tested in the NCI-H295R human adrenocortical car-
cinoma cell line (ATCC no. CRL-2128, LGC Standards, Boras, Sweden) as
previously described (Hecker et al., 2011). In brief cells were seeded in
24-well culture plates (Costar3524,Corning,NY, USA) with DMEM/F12
medium (Gibco, Paisley, UK) supplemented with 2.0% Nu-serum (BD
Sciences Denmark) along with 1% ITS+ premix (containing6.25 μg/ml
insulin, 6.25 μg/ml transferrin,6.25 ng/ml selenium,1.25 mg/ml BSA
and 5.35 μg/ml linoleic acid; BD Sciences Denmark) and incubated for
24 h at37 °C in a humidiﬁed atmosphere of 5% CO2/air. The pesticides
andmixtures were added (1 ml) to the cells in triplicates at six concen-
trations ranging from 1.6 to 100 μM, and left to incubate for 48 h.
Control wells (0 μM) contained the same amount of DMSO (0.1%) as ex-
posed cells. After the 48 h incubation period the mediumwas removed
and stored at−80 °C until the hormone analyses. Hormone levels were
normalized to the solvent control containing 0.1% DMSO. All hormone
measurements for single pesticides and mixtures were repeated in atleast three independent experiments. For evaluation of cytotoxicity,
cells were added 5 mg/ml MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) (cat. no. M2128, Sigma, St. Louis, USA)
once the media for the hormone analysis had been removed. After an
incubation period for approximately 1.5 h at 37 °C at 5% CO2 the MTT
was removed, and 0.5 ml isopropanol was added and the contents
were mixed for 5 min on a plate shaker (Hecker et al., 2011). Fluores-
cence was next measured (excitation 560 nm, emission 590 nm) on
Wallac Victor2 1420 multilabel counter (PerkinElmer, Massachusetts,
USA).
Hormone measurements. Hormones were extracted from cell super-
natants using a C18 solid phase extraction (SPE) cartridge (200 mg)
(prod. no. 220-0020-B, Mikrolab Aarhus Denmark) as previously de-
scribed (Vinggaard et al., 2002). The eluate was evaporated for approx-
imately 4 1/2 h in a centrifugal vacuum concentrator (SpeedVac,
Thermo Fisher Scientiﬁc, Waltham, MA, USA). Samples were re-
suspended in 200 ml Diluent 1 (PerkinElmer, Waltham, MA, USA) and
stored at 4 °C. Samples were next placed in a water bath for 10 min at
45 °C to dissolve the steroid hormones. Estradiol, progesterone and tes-
tosterone were measured using commercially available time-resolved
ﬂuoroimmunoassay kits (WallacDELFIA®) purchased fromPerkinElmer
(Skovlunde, Denmark) according to the description of themanufacturer
(Estradiol: prod. no. 1244-056, Progesterone: prod. no. A066-101, Tes-
tosterone: prod. no. A050-101).
Animals and exposure
The animal study was performed under conditions approved by the
Danish Animal Experiments Inspectorate and by the in-house Animal
Welfare Committee. The study included 84 time-mated Wistar rats
(HanTac:WH, Taconic Europe, Ejby, Denmark) supplied on gestational
day (GD) 3 and upon arrival, randomly distributed in pairs and housed
under standard conditions: semitransparent polycarbonate cages
(15 × 27 × 43 cm) with Aspen bedding (Tapvei, Denmark) situated in
an animal room with controlled environmental conditions (12 h light-
dark cycles with light starting at 9 p.m., light intensity 500 lx, tempera-
ture 21 ± 2 °C, humidity 50% ± 5%, ventilation 8 air changes per h). A
complete rodent diet for growing animals ALTROMIN 1314 (Soy- and
alfalfa-free ALTROMIN GmbH, Lage, Germany) and acidiﬁed tap water
(to prevent microbial growth) were provided ad libitum. The animals
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recorded daily during the experimental period.
The day after arrival, i.e.GD 4, animals wereweighed and distributed
into seven groups of 12 animals, with similar weight distributions. An
acclimatization period of 4 days was allowed before starting exposure.
Dams were exposed by gavage to pesticide mixtures daily from GD 7
to 21. At GD 21 the last dosing was performed 1–2 h before the dams
were euthanized. The study was performed in three blocks, with one
week in between each block (4 dams per dose group per block).
Group 1 received vehicle only. Groups 2, 3, and 4 received a 1:1:1 mix-
ture of bitertanol, propiconazole and cypermethrin in a total dose of 3,
9 and 30 mg/kg bw/day, respectively. Groups 5, 6, and 7 received a
1:1:1:1:1mixture of bitertanol, propiconazole, cypermethrin,malathion
and terbuthylazine in a total dose of 5, 15, and 50 mg/kg bw/day,
respectively.
Prior to conducting the in vivo study Draft Assessment Reports for
the ﬁve pesticides were evaluated, including looking at the reported
no observed adverse effect levels (NOAELs) and lowest observed ad-
verse effect levels (LOAELs) particularly from 2- and 3-generation stud-
ies as well as developmental toxicity studies conducted in rats. For the
selection of mixture doses it was a priority that the doses should not
cause any maternal toxicity. In the design of the in vivo study the mix-
tures were composed such that the pesticides were present at equal
doses (in mg/kg). The design of the mixtures was not based on equi-
effective doses as we did not have a speciﬁc dose for all selected pesti-
cides affecting the same endpoint such as e.g. anogenital distance,
which was one of the hormone sensitive endpoints prioritized in the
in vivo study. Furthermore, the ratios in themixtures were not intendedFig. 1. Effect on progesterone production in vitro. In vitro effects of the ﬁve single pesticides as
mean ± SD for one representative experiment out of three independent experiments. *Statistito reﬂect human exposure — as we are lacking information on humane
exposure levels for most – if not all – pesticides. The maximum dose of
each compound in the mixture, i.e. 10 mg/kg bw/day per compound,
was selected on the basis of previous toxicological data, typically from
2-generation studies, and the highest dose was equivalent to the dose
at which only subtle effects were expected on maternal body weights
and litter size.Cesarean sections GD 21
At GD 21 dams were weighed, anesthetized in CO2/O2 and decapi-
tated, and fetuses were removed by cesarean section as previously de-
scribed (Vinggaard et al., 2005).
Uteri were taken out, and the number of live fetuses, location in
uterus, resorptions, and implantations were registered. Amniotic ﬂuid
from each dam was collected in glass tubes and stored at −80 °C
until it was used for analysis of pesticides and metabolites as described
by Bossi et al. (2013). Body weight, sex, and any anomalies were
recorded. Anogenital distance (AGD), measured as the distance be-
tween the genital papilla and the anus, was measured in all fetuses
using a dissecting scope with an ocular reticle. AGD was analyzed
both with and without the cubic root of the body weight as a covariate.
This was done in order to take into account that the length of the AGD
may be inﬂuenced by the size of the fetus, and that while body weight
is a three dimensional measurement, AGD is one-dimensional. The
measurements were performed blinded with respect to treatment
group by a skilled technician.well as Mix 3 and Mix 5 on progesterone production in H295R cells. Data represent the
cally signiﬁcantly different from control (P b 0.05). C = cytotoxicity.
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Trunk blood from dams and fetuses was collected immediately after
decapitation into heparin-coated vials for hormone analysis; from the fe-
tuses one pool per litter was made for all male and female fetuses, re-
spectively. Steroid hormones were extracted on ISOLUTE SPE columns
from the serum as previously described (Birkhoj et al., 2004; Vinggaard
et al., 2002). The thyroid hormones triiodothyronine (T3) and thyroxine
(T4) were analyzed as previously described (Taxvig et al., 2008), and all
hormones were measured by use of Delﬁa time-resolved ﬂuorescence
kits (PerkinElmer), using a Wallac Victor 1420 multi-label counter
(PerkinElmer Life Sciences).
From the control group and each of the high dose mixture-groups
(Mix 3 30 mg/kg and Mix 5 50 mg/kg) placentas were taken from 3–4
dams. The level of testosterone and estradiol in the placentas was mea-
sured by pooling two placentas from one dam, placing the tissue in a
glass vial containing 1000 μl water. The tissue was homogenized, 4 ml
heptane was added to the vial, and then blended using a metal spatula.
The homogenatewas placed in a “bath” consisting of dry ice and acetone
until the water fractionwas frozen. The supernatant was transferred to a
new glass vial. The water fraction was extracted once more with 4 ml
heptane, cooled, and the supernatant pooled with the ﬁrst heptane frac-
tion. Heptane was evaporated by placing the vials in a water bath of
45 °C under nitrogen using TurboVap®LV (Biotage, Sweden). Before
analyzing, the samples were re-suspended in 100 μl Diluent 1
(PerkinElmer), and hormone concentrations were measured with a
Delﬁa time-resolved ﬂuorescence kit (PerkinElmer) and a Wallac Victor
1420multi-label counter (PerkinElmer Life Sciences) as described above.
Fetal testes were excised and sampled for 1)measurement of testic-
ular testosterone content, 2) incubation for 3 h to assess testicularFig. 2. Effect on testosterone production in vitro. In vitro effects of the ﬁve single pesticides as
mean ± SD for one representative experiment out of three independent experiments. *Statisttestosterone production ex vivo, and 3) ﬁxation for histopathological
examination. One testis from each of 2 male fetuses per litter was incu-
bated in media for 3 h at 37 °C, and frozen at −80 °C until measure-
ment of testosterone in the incubation media, as described previously
(Borch et al., 2006). One testis from each of two male fetuses per litter
was snap-frozen in empty tubes in liquid nitrogen before measurement
of testicular testosterone content. One testis from each of twomales per
litter was placed in Bouin's ﬁxative and processed for histology as de-
scribed in Borch et al. (2006). Hematoxylin and eosin stained fetal testes
were evaluated by an observer blinded to treatment groups and scored
for the presence of the following parameters: presence of multinuclear
gonocytes, clustering of gonocytes, increased numbers of gonocytes,
altered morphology of Leydig cells, clustering of Leydig cells, and disor-
ganization of structure of seminiferous chords or interstitial area.
mRNA levels determined by real-time RT-PCR
The adrenal gland from one male and one female per litter was
weighed and stored in RNAlater (Qiagen; Ballerup, Denmark) for
mRNA level analyses. RNA puriﬁcation and cDNA production were
done according to the procedure from themanufacturer and as described
in Laier et al. (2006).
mRNA levels were quantiﬁed on a Taqman 7900 HT qPCR apparatus
(Applied Biosystems) by standard TaqMan technology using TaqMan®
Fast Universal PCR Master Mix (Applied Biosystems). All mRNA levels
were quantiﬁed by the delta Ct method, and mRNA expression levels
of each target gene were normalized to the expression level of the
housekeeping gene 18S rRNA. Normalization was done by subtracting
the Ct value of 18S rRNA from the Ct value of the target gene, giving a
value named the delta Ct value (dCt). The 2−dCt values were thenwell as Mix 3 and Mix 5 on testosterone production in H295R cells. Data represent the
ically signiﬁcantly different from control (P b 0.05). C = cytotoxicity.
Table 2
Summery of in vitro effects.
Progesterone Testosterone Estradiol Max.
E2/T
In vitro
Propiconazole ↓ (50 μM) ↓ (50 μM) ↓ (2 μM) 0.6 (2 μM)
Cypermethrin ↑ (6–13 μM) ↔ ↑ (3 μM) 1.7 (13 μM)
Bitertanol ↓(33 μM) ↑(50 μM) ↓ (50 μM) ↓ (13 μM) 4.7 (13 μM)
Terbuthylazine ↑ (6 μM) ↑ (13 μM) ↑ (3 μM) 2.5 (50 μM)
Malathion ↑ (13 μM) ↑ (13 μM) ↑ (13 μM) 1.4 (25 μM)
Mix 3 ↑ (25 μM) ↓ (3 μM) ↓ (2 μM) 1.5 (3 μM)
Mix 5 ↑ (25 μM) ↓ (6 μM) ↑ (3 μM) 3.5 (6 μM)
↑: increase; ↓: decrease;↔: no effect.
The concentrations listed in brackets under the hormones are LOECs. The concentrations
listed after the E2/T ratio is the concentration giving the largest ratio.
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tween groups.
The following genes were quantiﬁed in male and female adrenal
glands: 18S rRNA, steroidogenic acute regulatory protein (StAR), cyto-
chrome P450-side-chain cleavage (P450scc), Cyp17a1 (P450c17),
peripheral benzodiazepine receptor (PBR/Bzrp), and the aromatase
(Cyp19) gene. The primer and probe sets were generated using the
Primer Express Software v2.0, from Applied Biosystems; nucleotide se-
quences are described in Taxvig et al. (2008).
Statistics
The statistical analyses of data with normal distribution and homo-
geneity of variance were analyzed using analysis of variance (ANOVA),
followed by Dunnett's post hoc test. When more than one pup from
each litter was examined, statistical analyses were adjusted using litter
as an independent, random and nested factor in ANOVA. Birth weights
were analyzed with the number of pups per litter as a covariate. In
cases where normal distribution and homogeneity of variance could
not be obtained by data transformation, a non-parametric Kruskal–Wal-
lis test was used (post-implantation loss). The statistical analyses were
performed using SigmaPlot version 11 (Systat Software, Inc., Chicago,
IL, USA) or SAS statistical software (SAS Institute Inc., Cary, NC, USA).
Results
Effects on steroidogenesis in vitro
The inﬂuence of the ﬁve single pesticides and the two pesticidemix-
tures on steroidogenesis was analyzed in the H295R assay.
For four out of the ﬁve pesticides an increase in progesterone pro-
duction was seen, with malathion and terbuthylazine as the mostFig. 3. Effect on estradiol production in vitro.In vitro effects of the ﬁve single pesticides as well as
one representative experiment out of three independent experiments. *Statistically signiﬁcantpotent, with the lowest observed effect concentrations (LOECs) at 12.5
and 6.3 μM, respectively (Fig. 1). Propiconazole showed a decreased
progesterone production, but only at the highest, non-cytotoxic concen-
tration of 50 μM(Fig. 1). For bothMix 3 andMix 5 an increase in proges-
terone production was seen, with LOECs of 25 μM (Fig. 1).
The effect on testosterone productionwas different for theﬁve single
pesticides. Malathion and terbuthylazine caused an increase in testos-
terone production, whereas bitertanol and propiconazole showed a de-
crease, with bitertanol being the most potent, with a LOEC of 1.6 μM
(Fig. 2). Cypermethrin did not show any effect on testosterone produc-
tion (Fig. 2). However, bothMix 3 andMix 5 led to a signiﬁcant decrease
in the testosterone production in the H295R cells with LOECs of 3.1 and
6.3 μM, respectively (Fig. 2). In accordance with the effect of the single
pesticides, Mix 3 caused the most pronounced testosterone-lowering
effect.
Concerning effects on estradiol production an increase was seen for
malathion, cypermethrin, and terbuthylazine, where terbuthylazineMix 3 andMix 5 on estradiol production inH295R cells. Data represent themean ± SD for
ly different from control (P b 0.05). C = cytotoxicity.
Table 3
Pregnancy data, fetal body weight and anogenital distance at GD21.
Control Mix3 3 mg/kg Mix3 9 mg/kg Mix3 30 mg/kg Mix5 5 mg/kg Mix5 15 mg/kg Mix5 50 mg/kg
No. of dams 11 12 11 12 12 10 12
Maternal bw (g) 315.0 + 18.7 314.8 + 12.7 311.7 + 12.6 303.0 + 16.1 310.8 + 16.0 321.7 + 18.6 316 + 16.4
Adjusted bw (g) 243.7 + 13.2 246.5 + 14.1 246.4 + 12.8 245.6 + 11.7 247.5 + 10.2 249.9 + 18.2 251.3 + 9.6
No. implantations 12.8 + 1.2 13.3 + 1.2 12.3 + 1.3 11.6 + 2.1 12.5 + 1.9 13.0 + 0.9 13.1 + 1.4
No. fetuses 12.5 + 1.3 12.3 + 2.0 11.9 + 1.7 10.5 + 3 11.1 + 2.6 12.6 + 1.2 12.2 + 2.2
% post implantation loss 2.1 + 3.6 8.6 + 10.6 2.5 + 6.2 11.0 + 14.8 10.6 + 20.3 3.1 + 4.1 6.8 + 14.1
% males 45.1 + 14.2 49.9 + 10.2 50.0 + 6.9 45.4 + 22.6 53.9 + 10.7 52.0 + 11.2 43.7 + 13.1
Fetal weight male (g) 3.74 + 0.38 3.63 + 0.52 3.52 + 0.34 3.52 + 0.30 3.80 + 0.25 3.91 + 0.34 3.62 + 0.24
Fetal weight female (g) 3.56 + 0.36 3.49 + 0.42 3.39 + 0.33 3.44 + 0.34 3.59 + 0.31 3.67 + 0.27 3.40 + 0.19
Male AGD (units) 21.40 + 0.79 20.76 + 1.39 21.17 + 0.78 21.56 + 0.63 21.35 + 0.96 21.47 + 0.82 21.02 + 1.25
Female AGD (units) 11.58 + 0.72 11.58 + 0.85 11.64 + 0.80 11.46 + 0.42 11.68 + 0.71 11.56 + 0.56 11.16 + 0.55
Data represent means ± SD of litter means.
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bitertanol a decrease was seen at the highest concentrations (LOEC of
12.5 μM) (Fig. 3), and for propiconazole a signiﬁcant decrease in estra-
diol levels was seen with a LOEC of 2 μM (Fig. 3). For Mix 3 and Mix 5
the effect on estradiol production was opposite; Mix 3 showed a clear
decrease with a LOEC of 2.6 μM, whereas Mix 5 showed a signiﬁcant in-
crease, with a LOEC of 3.1 μM (Fig. 3). Table 2 gives a summary of the
in vitro effects.Fig. 4. Plasma hormone levels in dams GD21. Plasma concentrations of A) estradiol, B), progest
GDs 7 to 21. Data represent the mean ± SD. n = 9–12 dams pr. dose group). *Indicate a statisIn vivo study
No effects were seen on maternal body weights or on the adjusted
maternal body weight, which is the body weight of the dam minus
the weight of the uterus with fetuses, placentas and ﬂuids. The number
of implantations and live fetuses as well as percent post-implantation
loss and percent males per litter were unaffected by the prenatal pesti-
cide exposure (Table 3). Nomorphological or histological changes wereerone, C) T4, and D) T3 in dams at GD21 following exposure to mixtures of pesticides from
tically signiﬁcant difference compared to controls (P b 0.05).
Fig. 6. mRNA expression levels of the aromatase gene. Expression of aromatase mRNA in
adrenal glands from female rat fetuses determined by quantitative PCR at GD 21. The fe-
tuses were exposed to the pesticide mixtures from GDs 7 to 21. The data represent the
values of the speciﬁc mRNA levels relative to the housekeeping gene 18S rRNA. Data are
mean ± SEM of 2−dCt values with all data in percent of the mean of the control group
(n = 10–12). *Indicates statistically signiﬁcant difference compared to controls (p b 0.05).
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(AGD) inmale and female fetuses (Table 3).Weights ofmale and female
fetuses were around 4–5% lower in the groups exposed to the highest
doses of the two pesticide mixtures, i.e. in Mix 3 30 mg/kg and Mix 5
50 mg/kg, but no statistically signiﬁcant effects were seen (Table 3).
Effect on hormone levels in dams. In plasma of dams exposed to the
highest dose of Mix 5 (50 mg/kg) a slight but signiﬁcant decrease was
found in the estradiol level (Fig. 4A) at GD 21. A signiﬁcant increase in
T4 was seen at 15 and 50 mg/kg Mix 5 (Fig. 4C), and for T3 a tendency
towards an increase with Mix 5 was seen as well, but the effect was
not statistically signiﬁcant (Fig. 4D). No signiﬁcant effect was found on
progesterone plasma concentrations in the dams at GD 21 (Fig. 4B).
Testosterone levels were measured in placentas from controls, from
the high doseMix 3 (30 mg/kg), and high doseMix 5 (50 mg/kg). A sta-
tistically signiﬁcant decrease in the level of testosterone was found in
placentas from the Mix 5 in the 50/mg/kg dose group (Fig. 5). The level
of estradiol in placental tissue could not be measured by the applied
method (because the level was below the limit of detection for the
analysis).
Effect on testis hormones and testicular histopathology GD 21. Testoster-
one levels were measured in testis from the male fetuses taken by cesar-
ean section on GD 21, but no effects were found for either Mix 3 or Mix 5
dose group (data not shown). Likewise, neither mixture had any effects
on the ex vivo testicular testosterone production (data not shown).
No dose-related changes in testicular histopathologywere observed.
A number of animals were noted as having disorganization of the inter-
stitial area, but this ﬁndingwas present in all dose groups and therewas
no sign of dose-relationship (data not shown).
Effects on gene expression levels. Gene expression analysis was per-
formed on fetal adrenal glands. In female fetuses exposed to 50 mg/kg
Mix 5 a statistically signiﬁcant increase in themRNA level of the aroma-
tase gene in adrenal glandswas found (Fig. 6). Inmale fetuses no signif-
icant effect on adrenal aromatase mRNA level was found (data not
shown). No other steroidogenic genes were affected in either male or
female fetuses (data not shown).
Pesticide levels in amniotic ﬂuid. The measurements of the pesticides
and their metabolites in the amniotic ﬂuid showed increasing concen-
trations with increasing exposure levels (Fig. 7). This is evident in
most cases, but for bitertanol inMix 3 there is a 7-fold difference in pes-
ticide level when the dose is increased 3-fold. However, this non-Fig. 5. Testosterone levels in placenta. The level of testosteronewasmeasured in placentas
followingmaternal exposure to mixtures of pesticides from GD 7 to 21. At GD 21 cesarean
sections were performed and placentas were collected from dams in the Mix3 30 mg/kg,
and the Mix 5 50 mg/kg dose groups, respectively. Data represent the mean ± SD. n =
3–4 dams pr. dose group. *Indicate a statistically signiﬁcant difference compared to con-
trols (P b 0.05).linearity disappears when bitertanol is dosed together with the four
pesticides in Mix 5.
The measurements showed that propiconazole was the parent pes-
ticide found in the lowest concentrations, whereas bitertanol was the
pesticide measured at the highest concentration. Relatively high
concentrations of the cypermethrin metabolite 3-phenoxybenzoic acid
(3-PBA) and the terbuthylazine metabolite desethylterbuthylazine
were also recovered in the amniotic ﬂuid (Fig. 7).
Discussion
The overall aim of the current study was to investigate the potential
endocrine activity of two selected pesticidemixtures consisting of fungi-
cides, insecticides, as well as an herbicide. Individually, these pesticides
were able to alter steroidogenesis in adrenal cells in vitro, with four out
of ﬁve pesticides increasing progesterone levels. Opposing effects of the
various pesticides were seen on estradiol and testosterone levels.
Gametogenesis and the early development of the fetus is a particu-
larly sensitive period for adverse effects of exposure to EACs (Hardell
et al., 2006; Sharpe, 2006; Skakkebaek, 2002). In the current study the
two selected pesticide mixtures, Mix 3 (bitertanol, propiconazole, and
cypermethrin) and Mix 5 (bitertanol, propiconazole, cypermethrin,
malathion, and terbuthylazine), were investigated in vivo by dosing
pregnant rats from GD 7 to GD 21, followed by examination of endo-
crine effects in dams, but in particular in the fetuses, which are consid-
ered very sensitive. Several currently used pesticides have recently been
reported being anti-androgens in vitro (Orton et al., 2011), and anti-
androgenic effects both in vitro and viamaternal exposure in vivo have
been reported for several pesticides including prochloraz, procymidone,
linuron, tebuconazole, and vinclozolin both singly and in mixtures
(Gray et al., 1999; Hass et al., 2012; Lambright et al., 2000; Ostby et al.,
1999; Taxvig et al., 2007; Uzumcu et al., 2004; Vinggaard et al., 2005).
In the current study no anti-androgenic effects or changes in the mea-
sured steroid hormone levels were found in the fetuses, and no effects
on AGD, testosterone levels, or histopathology were observed. This
means that it is likely that if any androgen receptor blocking or inhibi-
tion of testosterone synthesis took place in the gonads of the fetuses
at the applied dose levels, this was not detectable as a biological effect
on downstream endpoints. In contrast, a small but signiﬁcant decrease
in the estradiol plasma level was seen in the dams exposed to the
highest dose of Mix 5. Additionally, a signiﬁcant increase in the T4 plas-
ma concentration was found in dams exposed to the two highest doses
of Mix 5 (15 and 50 mg/kg). In contrast, in pregnant rats other pesti-
cides such as mancozeb have been found to reduce T4 levels in dams,
Fig. 7. Concentrations of pesticides andmetabolites in amnioticﬂuid. The level of pesticides andmetabolitesweremeasured in amnioticﬂuid from rats exposed to pesticide A)Mix 3 or B)
Mix 5 fromGDs 7 to 21. Data representsmean ± SD (n = 5). The data presented in thisﬁgure are also presented in a differentway and in a different context in themethod paper by Bossi
et al. (2013).
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2011), and prochloraz and p,p′-DDE exposure has also been shown to
reduce T4 levels in adult male rats (O'Connor et al., 1999; Vinggaard
et al., 2002). As dams transfer thyroid hormones (THs) to their fetuses,
it may be expected that amodest increase in T4 would not result in a se-
vere adverse effect (Morreale de Escobar et al., 1987). This is also sup-
ported by the fact that, in humans as well as in rats, reduced levels of
THs during early prenatal life have been associated with adverse effects
e.g. impaired neurological development (Crofton, 2004; Haddow et al.,
1999; Hendrich et al., 1984; Li et al., 2010; Porterﬁeld and Hendrich,
1981).
In addition to the reduced estradiol levels in the dams from theMix 5
50 mg/kg dose group, a signiﬁcant decrease in the level of testosteroneFig. 8. Summary ofMix 5-induced effects in vivo. Theﬁgure presents a hypothesis for a link betw
withMix 5 50 mg/kg. The placenta is the primary site of estradiol synthesis during pregnancy. In
theplacenta is inhibited. As theprecursor for placental steroidogenesis is dehydroepiandrostero
hypothesize that a general inhibition of DHEA synthesis has takenplace in the fetus. In addition,
50 mg/kg. Whether the aromatase induction in the fetus is a secondary effect to the proposedwas also found in the placentas from the Mix 5 50 mg/kg dose group.
As the placenta is the primary site of estrogen synthesis during pregnancy
(Kaludjerovic andWard, 2012), it is likely that steroidogenesis in placenta
is inhibited, as indicated by the lowered testosterone levels. As the pre-
cursor for placental steroidogenesis is dehydroepiandrosterone (DHEA)
produced primarily by the fetal adrenal cortex (Kaludjerovic and Ward,
2012), we hypothesize that a general inhibition or reduction of DHEA
synthesis takes place in the fetus (Fig. 8). In addition, an increase in the
mRNA level of the aromatase gene in fetal adrenal glands from the
highest Mix 5 dose group was seen; however this effect was only
observed in the female offspring indicating important sex differences in
either ADME (absorption, distribution, metabolism, and excretion)
related issues, Cyp19 gene regulation, or differences related to steroideen the effects observed forMix 5: in vivo estradiol levelswere reduced in the dams dosed
placentawe found a signiﬁcant decrease in testosterone indicating that steroidogenesis in
ne (DHEA),mainly produced by the fetal adrenal cortex (Kaludjerovic andWard, 2012),we
an increase in aromatasemRNA levelswere found in female fetal adrenal glandswithMix 5
inhibition of DHEA synthesis, or it is a separate event, we do not know.
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tion in the female fetus is a secondary effect to the suggested inhibition in
DHEA synthesis, or it is a separate independent event (Fig. 8).
The in vitro data from theH295R steroidogenesis assay showed a de-
crease in the testosterone production for both mixtures, and for Mix 5
an increase in estradiol was also observed. This effect of Mix 5 can be
explained by an increased aromatase activity, which would be in accor-
dance with the observed increase in the aromatase mRNA level seen in
the female adrenal glands. Still, the induction of aromatase mRNA only
gives an indication that the aromatase enzyme activity might be
increased.
EACs can act via multiple modes of action including direct interac-
tion with steroid hormone receptors, or altered steroidogenesis. Cyto-
chrome P450 (Cyp) enzymes play a critical role in steroidogenesis,
and it is known from previous studies that many pesticides have the
ability to alter the activity of Cyp enzymes. Particularly the aromatase
(Cyp19) enzyme has been found as a target for many pesticides, some
pesticides inducing the activity and others inhibiting it (Sanderson
et al., 2002; Vinggaard et al., 2000; Zarn et al., 2003). Propiconazole
and other azole fungicides have been shown to inhibit aromatase
activity (Kjeldsen et al., 2013), whereas cypermethrin and triazine her-
bicides have been reported to induce the activity in vitro (Laville et al.,
2006; Sanderson et al., 2001; Trosken et al., 2006; Zarn et al., 2003).
As the observed effects in vivo were only seen for Mix 5, it suggests
that one or both pesticides speciﬁc for Mix 5, terbuthylazine and/or
malathion are driving the effect. The in vitro data in H295R cells indicate
that terbuthylazine and malathion by themselves have an overall stim-
ulatory effect on the steroid hormone synthesis, increasing progester-
one, testosterone and estradiol. Terbuthylazine is however causing
relatively higher increases in estradiol production in H295R cells (max-
imum estradiol/testosterone ratio of 2.5 and 1.4 for terbuthylazine and
malathion, respectively) suggesting aromatase induction. Thus, it is
likely that terbuthylazine is the compound driving the effect of Mix 5
on aromatase activity in vivo. However, data from this in vivo study do
not provide the full evidence that aromatase induction is the dominat-
ing mechanism of action for Mix 5 in vivo.
In the current in vivo study a novel approach was applied to analyze
for pesticides and their metabolites in amniotic ﬂuid (Bossi et al., 2013),
and these levels are close to representing the actual dose at the target i.e.
in the fetus. It was possible to detect all ﬁve pesticides in the amniotic
ﬂuid, demonstrating that the fetuses were exposed to these chemicals
(Bossi et al., 2013). However, it is possible that the internal dose in the
fetuses was too low to cause any effect on AGD or fetal hormone levels.
Overall, it is an interesting observation that the levels of the three
pesticides present in both Mix 3 and Mix 5 were lower, when they
were combined with terbuthylazine and malathion in Mix5 (Fig. 7 and
Bossi et al., 2013). This indicates ADME interactions resulting in lower
exposure when more chemicals are given at relatively high doses
(10 mg/kg). Whether this is due to an affected absorption, distribution,
metabolism, and/or excretion of the pesticides remains unknown.How-
ever, the lower levels of the same pesticides inMix 5 compared toMix 3
indicate that this effect is not primarily due to saturated metabolism.
The bitertanol levels in Mix 3 increase in a non-linear fashion and this
might be explained by saturated metabolism. However, this non-
linearity is not observed for bitertanol inMix 5, indicating that the pres-
ence of terbuthylazine and/ormalathion reduce bitertanol levels or lead
to more complex ADME interactions.
Altogether, it is likely that discrepancies between in vitro and in vivo
results could partly be due to ADME interactions andmetabolismof par-
ent compounds that occur in vivo, but not in vitro. Nevertheless, for Mix
5 alone there seems to be reasonable agreement between in vivo and
in vitro observations, as aromatase induction is evident both in vitro
and in vivo. Terbuthylazine alone has an overall stimulatory effect on
testosterone production, but causes amore potent and efﬁcient increase
in estradiol levels, which is in agreement with the in vitro data onMix 5
showing a clear indication of increased aromatase activity.In conclusion, all ﬁve single pesticides, as well as bothmixtures, had
the ability to affect steroidogenesis in vitro, and at the highest dose Mix
5 also exerted endocrine activity in dams as well as female fetuses, in
terms of disrupted hormone levels and affected the aromatase mRNA
level (Fig. 8).
Overall, the human H295R cell assay can give important hints on
potential chemically-induced effects on steroidogenesis that can be fur-
ther investigated in vivo. Supplementing the examination on steroido-
genesis with a battery of in vitro assays covering various mechanisms
of actionwill provide a good basis for generating hypotheses on relevant
mechanisms and in vivo effects.
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